Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00321711
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-02
Brief Title:
Determination of Safe and Effective Dose of Romiplostim AMG 531 in Subjects With Myelodysplastic Syndrome MDSReceiving Hypomethylating Agents
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-02
First Submit QC Date:
May 2 2006
Study First Post Date:
2006-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-04-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-20
Last Update Post Date:
2018-10-17
Last Update Post Date Type:
ACTUAL